RHYTHM PHARMACEUTICALS, INC. (RYTM) › Operating Cash FlowRHYTHM PHARMACEUTICALS, INC. (RYTM) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2015: -$6.75M2016: -$23.22M2017: -$29.46M2018: -$62.06M2019: -$122.75M2020: -$121.98M2021: -$146.00M2022: -$173.43M2023: -$136.16M2024: -$113.88M2025: -$115.67M-$115.67M2015Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$115.67M-1.6%2024-$113.88M+16.4%2023-$136.16M+21.5%2022-$173.43M-18.8%2021-$146.00M-19.7%2020-$121.98M+0.6%2019-$122.75M-97.8%2018-$62.06M-110.6%2017-$29.46M-26.9%2016-$23.22M-243.9%2015-$6.75M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share